In summary, we analyzed the prognosis-related genes of NB using bioinformatics technology, identified a potential therapeutic drug, BI-D1870, and confirmed that BI-D1870 can effectively inhibit the growth of NB. Here, CACNA1A is linked to neuroblastoma.